Midway through trading Friday, the Dow traded down 0.71% to 25221.42 while the NASDAQ fell 0.08% to 9361.25. The S&P also fell, dropping 0.46% to 3015.85.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 1,721,920 cases with around 101,620 deaths. Brazil confirmed a total of over 438,230 COVID-19 cases with 26,750 deaths, while Russia reported a total of at least 387,620 confirmed cases and 4,370 deaths. In total, there were at least 5,831,160 cases of COVID-19 worldwide with over 360,860 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Consumer discretionary shares rose 0.02% on Friday. Meanwhile, top gainers in the sector included Williams-Sonoma, Inc. WSM 13.92%, up 16%, and U.S. Auto Parts Network, Inc. PRTS 9.09%, up 9%.
In trading on Friday, energy shares fell 1.3%.
Top Headline
Big Lots, Inc. BIG 5.6% reported better-than-expected results for its first quarter.
Big Lots reported quarterly earnings of $1.26 per share on Friday, which exceeded the analyst consensus estimate for earnings of $0.32 per share. The company reported quarterly sales of $1.44 billion, versus the analyst consensus estimate of $1.31 billion. Its same-store sales climbed 10.3% during the quarter.
Equities Trading UP
Sonoma Pharmaceuticals, Inc. SNOA 135.49% shares shot up 172% to $14.70 after the company announced that its Nanocyn Disinfectant & Sanitizer has received approval to be entered into the Austrialian registered of therapeutic goods to be used for use against coronavirus.
Shares of Phio Pharmaceuticals Corp. PHIO 87.05% got a boost, shooting 94% to $4.35 after the company reported positive data from in vivo studies that show strong antitumoral efficacy.
Adaptimmune Therapeutics plc ADAP 139.51% shares were also up, gaining 97% to $9.58 following an updated clinical readout from the company. The Philadelphia-based company said updated data from its Phase 1 study dubbed SPEARHEAD-1 that evaluated its ADP-A2M4, presented at the ASCO 2020 Annual Meeting, showed durability and responses in synovial sarcoma. Thisrenders the study as a potential registrational trial, the company said.
Equities Trading DOWN
Minerva Neurosciences, Inc. NERV 79.55% shares tumbled 80% to $2.66 after the company reported results from Phase 3 Trial of Roluperidone for the treatment of negative symptoms in schizophrenia.
Shares of Canopy Growth Corporation CGC 19.35% were down 20% to $17.34 following Q4 results. Canopy Growth posted a Q4 loss of C$3.72 per share, versus a year-ago loss of C$1.10 per share.
Arvinas, Inc. ARVN 29.52% was down, falling 29% to $32.00 after the company reported updated data from the dose escalation portion of its Phase 1/2 clinical trial of ARV-110 in men with metastatic castration-resistant prostate cancer.
Commodities
In commodity news, oil traded down 0.4% to $33.57, while gold traded up 1.2% to $1,748.50.
Silver traded up 2.3% Friday to $18.385, while copper fell 0.2% to $2.4095.
Euro zone
European shares were lower today. The eurozone’s STOXX 600 fell 1.44%, the Spanish Ibex Index fell 1.52%, while Italy’s FTSE MIB Index slipped 1%. Meanwhile, the German DAX dropped 1.4%, and the French CAC 40 fell 1.4% while UK shares fell 2.1%.
Economics
U.S. goods deficit increased to $69.68 billion in April, versus $64.99 billion in the earlier. Exports dipped 25.2% to $95.37 billion, while imports declined 14.3% to $165.05 billion.
U.S. personal income climbed 10.5% in April, versus a revised 2.2% decline in March. Personal spending dropped 13.6% in April, following a revised 6.9% drop in March.
U.S. wholesale inventories increased 0.4% in April, versus a revised 1% decline in March.
The Chicago PMI fell to 32.3 in May, versus a reading of 35.4 in April.
The University of Michigan's consumer sentiment index dropped to 72.3 in May, versus preliminary reading of 73.7.
The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
Data on farm prices for April will be released at 3:00 p.m. ET.
Benzinga does not provide investment advice. All rights reserved.
Recommended Content
Editors’ Picks
EUR/USD holds above 1.0700 ahead of key US data
EUR/USD trades in a tight range above 1.0700 in the early European session on Friday. The US Dollar struggles to gather strength ahead of key PCE Price Index data, the Fed's preferred gauge of inflation, and helps the pair hold its ground.
USD/JPY stays above 156.00 after BoJ Governor Ueda's comments
USD/JPY holds above 156.00 after surging above this level with the initial reaction to the Bank of Japan's decision to leave the policy settings unchanged. BoJ Governor said weak Yen was not impacting prices but added that they will watch FX developments closely.
Gold price oscillates in a range as the focus remains glued to the US PCE Price Index
Gold price struggles to attract any meaningful buyers amid the emergence of fresh USD buying. Bets that the Fed will keep rates higher for longer amid sticky inflation help revive the USD demand.
Sei Price Prediction: SEI is in the zone of interest after a 10% leap
Sei price has been in recovery mode for almost ten days now, following a fall of almost 65% beginning in mid-March. While the SEI bulls continue to show strength, the uptrend could prove premature as massive bearish sentiment hovers above the altcoin’s price.
US core PCE inflation set to signal firm price pressures as markets delay Federal Reserve rate cut bets
The core PCE Price Index, which excludes volatile food and energy prices, is seen as the more influential measure of inflation in terms of Fed positioning. The index is forecast to rise 0.3% on a monthly basis in March, matching February’s increase.